533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study. - Abdel-Razeq, H.; Alsayed, A.; Dawoud, E.; Al Kharusi, S.S.; Hammad Tirmazy, S.; Ahmed, E.; Alhawari, L.; Kasseb, M.; Soliman, W. (Annals of Oncology, 2025)